Kraig Biocraft Labs Stock Fundamentals
| KBLB Stock | USD 0.08 0 2.50% |
Kraig Biocraft Labs fundamentals help investors to digest information that contributes to Kraig Biocraft's financial success or failures. It also enables traders to predict the movement of Kraig OTC Stock. The fundamental analysis module provides a way to measure Kraig Biocraft's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kraig Biocraft otc stock.
Kraig |
Kraig Biocraft Labs OTC Stock Current Valuation Analysis
Kraig Biocraft's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Kraig Biocraft Current Valuation | 34.14 M |
Most of Kraig Biocraft's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kraig Biocraft Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Kraig Biocraft Labs has a Current Valuation of 34.14 M. This is 99.7% lower than that of the Chemicals sector and 99.89% lower than that of the Materials industry. The current valuation for all United States stocks is 99.79% higher than that of the company.
Kraig Biocraft Labs Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kraig Biocraft's current stock value. Our valuation model uses many indicators to compare Kraig Biocraft value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kraig Biocraft competition to find correlations between indicators driving Kraig Biocraft's intrinsic value. More Info.Kraig Biocraft Labs is rated below average in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kraig Biocraft by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kraig Biocraft's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Kraig Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kraig Biocraft's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Kraig Biocraft could also be used in its relative valuation, which is a method of valuing Kraig Biocraft by comparing valuation metrics of similar companies.Kraig Biocraft is currently under evaluation in current valuation category among its peers.
Kraig Fundamentals
| Return On Asset | -0.32 | |||
| Current Valuation | 34.14 M | |||
| Shares Outstanding | 1.02 B | |||
| Shares Owned By Insiders | 25.29 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | (9.37) X | |||
| Price To Sales | 1,199 X | |||
| EBITDA | (2.64 M) | |||
| Net Income | (8.05 M) | |||
| Cash And Equivalents | 4.82 M | |||
| Total Debt | 95.24 K | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 38 | |||
| Beta | 0.34 | |||
| Market Capitalization | 38.03 M | |||
| Total Asset | 3.02 M | |||
| Retained Earnings | (22.47 M) | |||
| Working Capital | (2.32 M) | |||
| Current Asset | 356 K | |||
| Current Liabilities | 2.68 M | |||
| Net Asset | 3.02 M |
About Kraig Biocraft Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kraig Biocraft Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kraig Biocraft using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kraig Biocraft Labs based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 38 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kraig OTC Stock
Kraig Biocraft financial ratios help investors to determine whether Kraig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kraig with respect to the benefits of owning Kraig Biocraft security.